Member Info for dactions

Jamrock and any other concerned shareholders.

There's no denying the MD's somewhat disdain for shareholders as seen by missed follow-ups as to trading news. But here we have a definite missed date - July as declared by her in the May RNS.

I suggest an email to the company and/or their nominated broker asking why ?

Tefteresia - welcome to LSE but we are talking about the Trading Update not the Results.

2021 it was announced 7th July, for 2022 it was 20th July and more importantly, the MD announced in the May statement earlier this year:

"A trading update for the six months ended 30 June 2023 will be provided in July"

The MD is not good on keeping the shareholders up to date.

I think he’s had enough of working alongside Penny. She clearly has a strong personality and I suspect is difficult to be enthused with her style. We’ve seen it ourselves with the paucity of regular financial news.

Lucy Tobin aka The Tipster in Sunday Times headlined her piece this Sunday as 'Futura is looking for rapid growth'

She reminds readers that it has only 14 staff/directors working out of a small Surrey University Science park. She says that Futura has made a product that works and it is only just starting to shout about it. She makes clear things we might forget that Futura has minimised risk by outsourcing all it can; it does the science, but then, said James Barder, CEO "looks for commercial partners to do the rest." "We've done so in the UK, Europe and 7 countries in the Middle East. Saudi approval is expected in September - that's the biggest ED market in the Middle East." She was a day early for today's news re the US and probably thought like us it would fly.

It hasn't - but as sure as night follows day, unless male appendages start to shrink from too much Eroxon, then we are in for a sustained shareprice growth sooner or later. Initial sales at Boots were phenomenal - we know that - eventually these figures will become well known in the market and others will want their share of the action. Sit tight everyone our day is coming.

I notice last year's interim trading results for the 6 months to 30th June came out 20th July - which was a Wednesday. So perhaps this week we'll hear something.

I just hope it's substantive as so much that is said by the Board isn't frankly worth anything - I hesitate to say this but if we're honest with ourselves it could almost be described as 'waffle'. We're not getting specific numbers as to how these wellness products are performing. I understand Boots are showcasing the range in some large London/City stores but I haven't seen anything myself. Despite averaging down my breakeven is 27p and I'm sitting on quite a loss.

This can bounce on the right news but it's still looking a risky bet if the wellness isn't performing as we'd like to think it is. I was against the Consolidation as it doesn't by itself sort anything. Decent financial regular reporting to shareholders is all that matters in my opinion - let's hope this week we'll get decent news.

Bottom_feeder - I suspect you are right that Haleon has the better deal but that doesn't mean I have to agree with you as regards the future for us as shareholders in Futura. We've seen that slowly slowly we have made good progress with our link with Coopers in Europe and there is nothing at this stage to suggest otherwise when it comes to the US.

It's difficult to judge what Lombrad Odier's long-term ambitions are with FUM - to some extent that is holding the shareprice back - but once we have some financial data beyond just these upfront payments, as good as they are, we'll not really see the shareprice take off.

Brugge95 - the shareprice for FUM is quite an enigma.

Amazingly in years past the sp was higher than now when no trials had been completed - all on the promise that it would work. I can think back to 10 years ago paying the same price for the shares as now. I wonder if because of the nature of the principal product being one for a basic human use (we have yet to make any progress in the topical painkiller or cannabis compounds markets). Is the product too unsavoury, too seedy a background for many investors ?

Most new and upcoming businesses, see their sp making great strides early on, simply on imagined prospects whereas I've long felt that it is only on actual sales and profit figures that we will really see FUM's sp move. It's been a long game slowly unfolding with FUM, some will say it will happen once news of the US participant is announced but that's only one more step forward.

Once those financial figures are out and we can clearly see for ourselves it's not another emperor wearing new clothes (sorry to Hans Christian Andersen for bringing sex into your splendid parable) - then I'm quite sure the sp will rise and quickly go beyond £1 and this should become a true cash cow of a share. Until then, patience is the name of the game here - it will be rewarded I am quite sure. GLA

Tough call David ? I’m not sure it is as I think with the low take up shares lately there’s not a lot that will lift the sp until we get some sales news of the new products. As a lth myself we have seen these troughs before - by rights we should be pushing ahead rather than sinking but our profile isn’t high.

We have yet to see any meaningful reviews in Trustpilot on the new products , some of which have been on sale for many months. It is very frustrating at the moment.

They certainly appear to be BUYs as other smaller purchases were going through at around 59p Friday afternoon. So, if that is the case, why such a drop in the sp Friday to Monday ??

The medium term case for FUM is without doubt strong - the product is selling - we know that - and in very good volumes as far as we can tell. Is it MMs making a book for themselves or might we get a TR1 shortly that Lombard Odier have reduced their holdings ?

I’m heartened by today's RNS of a new non-executive Director who has extensive experience in pregnancy testing. She’s been providing consultancy to MHC in recent months - interestingly her company was acquired by Philips. Is it any coincidence that another non-exec Neil Mesher is a leading Manager for Philips Europe ?

Perhaps these two non-execs might push management along a bit faster ?

I got that marketing message too - smudge99 - I agree with your thoughts as to what it signifies but I suppose it’s an initial step to reach out to its email base of contacts. Boy how I wish the board would do something significant for its suffering shareholders.

You’ve hit the point spot on Henners007 - this will be used for recreational use and the market is staggeringly large - it’s just a case of time for us as I’m sure we’ll have the market to ourselves at least for a few years. GLA

I feel after all this time that we’ve had more RNS ‘s for options than anything else - speaks volumes in my opinion 😩

Today’s RNS continues the excellent news flow which has helped propel the advance in the company’s shareprice. It does seem to me that this is likely to continue to be the case for the rest of the year as more commercial deals get announced.

The early sales figures given for the half year are in themselves transformational in such a short period and augurs well for the 2nd half.

Looking very good for us all.

How right you are - discoman1 - the Eroxon Facebook page is massively loaded with pics & comments - all to the good for sales in the months ahead and of course the shareprice.

Kdonkey1000 - in my excitement after all these years with FUM getting myself in a muddle with dates. You’re explanation is great - thanks.

With analysts meeting this Friday should help promote news editorial over the weekend. Then Monday’s shareholders/investors meeting should help maintain a firm sp through next week.

I’d like to think this time next week the sp will be even higher than now.

I'm sure sales figures are going to be good - initial ones are bound to be iffy - how can anyone expect otherwise but having said that the product is staring you in your face in our local Boots. Long term this augers well.

Good point dosanddonts - I think I first bought these 2013 paying something like 60p. Admitted I bought a whole lot more in the 7p placing but what a stress ride it’s been - total failure at points but turned into success somehow - goodness knows someone ‘up there’ must have been correcting Barder’s mistakes.

Still it is where it is - according to the Boots website, it’s flying off the shelves- we know it costs a modest amount to make - so sooner or later we’re going to see great financials. Then it will finally rise and stay there. GLA

Many of us had thought LO would have converted some/all warrants when the sp was in the mid 50s but gradually this board started talking itself into the risk of the FDA turning it down - and I expect LO too felt that way.

Which in my opinion explains why they jumped yesterday. What will move this sp and rise consistently, is sales news & more sales news.

Margins are going to be massive even if the sales price slips - this is an obvious slow burner now going one way - upwards. Patience a little longer will reap big rewards. GLA